中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
9 结果
BACKGROUND
Dengue virus (DENV) infection remains an international public health problem affecting urban populations in tropical and sub-tropical regions, where it is currently estimated that about 2.5 billion people are at risk. Dengue virus is a single positive-stranded RNA virus of the family
BACKGROUND OF THE INVENTION
Dengue remains an international public health problem affecting urban populations in tropical and sub-tropical regions, where it is currently estimated that about 2.5 billion people are at risk of dengue infection. Dengue virus is a single positive-stranded RNA virus of
Controlled-release formulations of interleukin-2
只有注册用户可以翻译文章
登陆注册
BACKGROUND OF THE INVENTION
This invention is in the general fields of biochemical engineering and veterinary medicine. More specifically, this invention relates to improved, controlled-release formulations containing human interleukin-2 (hIL-2) and derivatives thereof for administration to
Antibodies to IL-6 and use thereof
只有注册用户可以翻译文章
登陆注册
The sequence listing in the file named "43272o1806.txt" having a size of 331,953 bytes that was created May 29, 2015 is hereby incorporated by reference in its entirety.
BACKGROUND
1. Field of the Art
This invention is an extension of Applicants' prior invention disclosed in the above-referenced
The sequence listing in the file name "56256o1808" having a size of 43,704 bytes that was created Mar. 22, 2018 is hereby incorporated by reference in its entirety.
BACKGROUND OF THE INVENTION
Field of the Invention
This invention is an extension of Applicants' prior invention disclosed in the
Antibodies to IL-6 to inhibit or treat inflammation
只有注册用户可以翻译文章
登陆注册
The sequence listing in the file named "43272ol1805.txt" having a size of 341,671 bytes that was created Apr. 3, 2014 is hereby incorporated by reference in its entirety.
BACKGROUND
1. Field of the Art
This invention is an extension of Applicants' prior invention disclosed in the above-referenced
Antibodies to IL-6 and use thereof
只有注册用户可以翻译文章
登陆注册
BACKGROUND
1. Field of the Art
This invention is an extension of Applicants' prior invention disclosed in the above-referenced patent applications relating to novel anti-IL-6 antibodies, novel therapies and therapeutic protocols utilizing anti-IL-6 antibodies, and pharmaceutical formulations
BACKGROUND OF THE INVENTION
Field of the Invention
This invention is an extension of Applicants' prior invention disclosed in the above-referenced patent applications relating to novel anti-IL-6 antibodies, novel therapies and therapeutic protocols utilizing anti-IL-6 antibodies, and pharmaceutical
Method of treating allergic asthma with antibodies to IL-6
只有注册用户可以翻译文章
登陆注册
The sequence listing in the file named "56256o2006.txt" having a size of 332,224 bytes that was created Sep. 26, 2017 is hereby incorporated by reference in its entirety.
BACKGROUND OF THE INVENTION
Field of the Invention
This invention is an extension of Applicants' prior invention disclosed in the
科学支持的最完整的草药数据库
- 支持55种语言
- 科学支持的草药疗法
- 通过图像识别草药
- 交互式GPS地图-在位置标记草药（即将推出）
- 阅读与您的搜索相关的科学出版物
- 通过药效搜索药草
- 组织您的兴趣并及时了解新闻研究，临床试验和专利
输入症状或疾病，并阅读可能有用的草药，输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究
